CN101495122B - 使用定量吸入器给予曲前列尼 - Google Patents

使用定量吸入器给予曲前列尼 Download PDF

Info

Publication number
CN101495122B
CN101495122B CN2007800239379A CN200780023937A CN101495122B CN 101495122 B CN101495122 B CN 101495122B CN 2007800239379 A CN2007800239379 A CN 2007800239379A CN 200780023937 A CN200780023937 A CN 200780023937A CN 101495122 B CN101495122 B CN 101495122B
Authority
CN
China
Prior art keywords
treprostinil
dose inhaler
metered dose
treatment
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2007800239379A
Other languages
English (en)
Chinese (zh)
Other versions
CN101495122A (zh
Inventor
H·奥尔舍夫斯基
R·罗希格诺
L·J·鲁宾
T·施梅尔
W·泽格
C·斯特里特
R·福斯温克尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Therapeutics Corp
Original Assignee
United Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38544006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101495122(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by United Therapeutics Corp filed Critical United Therapeutics Corp
Publication of CN101495122A publication Critical patent/CN101495122A/zh
Application granted granted Critical
Publication of CN101495122B publication Critical patent/CN101495122B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2007800239379A 2006-05-15 2007-05-14 使用定量吸入器给予曲前列尼 Active CN101495122B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80001606P 2006-05-15 2006-05-15
US60/800,016 2006-05-15
PCT/US2007/068884 WO2007134292A2 (en) 2006-05-15 2007-05-14 Treprostinil administration using a metered dose inhaler

Publications (2)

Publication Number Publication Date
CN101495122A CN101495122A (zh) 2009-07-29
CN101495122B true CN101495122B (zh) 2011-10-05

Family

ID=38544006

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800239379A Active CN101495122B (zh) 2006-05-15 2007-05-14 使用定量吸入器给予曲前列尼

Country Status (8)

Country Link
US (10) US20080200449A1 (cg-RX-API-DMAC7.html)
EP (1) EP2026816B1 (cg-RX-API-DMAC7.html)
JP (4) JP5797376B2 (cg-RX-API-DMAC7.html)
KR (1) KR101390579B1 (cg-RX-API-DMAC7.html)
CN (1) CN101495122B (cg-RX-API-DMAC7.html)
CA (1) CA2654492C (cg-RX-API-DMAC7.html)
ES (1) ES2707548T3 (cg-RX-API-DMAC7.html)
WO (1) WO2007134292A2 (cg-RX-API-DMAC7.html)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005020269D1 (de) * 2004-04-12 2010-05-12 United Therapeutics Corp Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
US20080200449A1 (en) 2006-05-15 2008-08-21 United Therapeutics Corporation Treprostinil administration using a metered dose inhaler
DE102006026786A1 (de) 2006-06-07 2007-12-13 Joachim Kern Dosierinhalator
CA2678258A1 (en) * 2007-02-09 2008-08-14 United Therapeutics Corporation Treprostinil treatment for interstitial lung disease and asthma
KR101898407B1 (ko) 2007-12-17 2018-09-12 유나이티드 세러퓨틱스 코오포레이션 레모둘린®의 활성 성분인 트레프로스티닐의 개선된 제조 방법
WO2009115235A1 (en) * 2008-03-20 2009-09-24 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of pulmonary hypertension
US8350079B2 (en) * 2008-05-08 2013-01-08 United Therapeutics Corporation Treprostinil formulation
WO2010036798A1 (en) * 2008-09-25 2010-04-01 Aradigm Corporation Deep lung pulmonary delivery of treprostinil
JP5649645B2 (ja) * 2009-05-07 2015-01-07 ユナイテッド セラピューティクス コーポレイション プロスタサイクリンアナログの固形製剤
US8551528B2 (en) 2009-06-12 2013-10-08 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US8609728B2 (en) 2010-03-15 2013-12-17 United Therapeutics Corporation Treatment for pulmonary hypertension
CA3029711A1 (en) 2010-06-03 2011-12-08 United Therapeutics Corporation Treprostinil production
US20130345471A1 (en) 2011-03-02 2013-12-26 United Therapeutics Corporation Synthesis of intermediate for treprostinil production
TWI602568B (zh) * 2011-04-26 2017-10-21 維克多瑞有限責任公司 以氣膠氣囊之伊洛前列素（ｉｌｏｐｒｏｓｔ）之投藥方法
CN103193627B (zh) 2012-01-10 2016-04-20 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
CN103193626B (zh) 2012-01-10 2016-05-11 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
US9387214B2 (en) 2012-01-13 2016-07-12 United Therapeutics Corporation Method of identifying therapies for pulmonary hypertension
ES2974809T3 (es) * 2012-10-31 2024-07-01 Vectura Gmbh Administración de iloprost en aerosol
CN104822372A (zh) * 2012-11-30 2015-08-05 英斯梅德股份有限公司 前列环素组合物及其使用方法
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
JP6542128B2 (ja) 2013-01-11 2019-07-10 コルセア ファーマ インコーポレイテッド トレプロスチニルのプロドラッグ
CA3212313A1 (en) 2013-03-14 2014-10-02 United Therapeutics Corporation Solid forms of treprostinil
KR102405650B1 (ko) 2013-03-15 2022-06-03 유나이티드 세러퓨틱스 코오포레이션 트레프로스티닐의 염
ES2754388T3 (es) 2013-03-15 2020-04-17 Mannkind Corp Composiciones y métodos de dicetopiperazina microcristalina
ES2676447T3 (es) 2013-03-25 2018-07-19 United Therapeutics Corporation Procedimiento de fabricación de compuestos de prostaciclina con tiol de unión y formas pegiladas
AU2014290438B2 (en) 2013-07-18 2019-11-07 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
MX382833B (es) 2013-10-25 2025-03-13 Insmed Inc Compuestos derivados de prostaciclinas, y el uso de los mismo para el tratamiento de la hipertension pulmonar
US20160317542A1 (en) 2013-12-09 2016-11-03 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
US20170095432A1 (en) 2014-06-13 2017-04-06 United Therapeutics Corporation Treprostinil formulations
ES2778274T3 (es) 2014-10-20 2020-08-10 United Therapeutics Corp Síntesis de productos intermedios para producir derivados de prostaciclina
JP6866043B2 (ja) 2014-11-18 2021-04-28 インスメッド インコーポレイテッド トレプロスチニルプロドラッグおよびトレプロスチニル誘導体プロドラッグの製造方法
WO2016088119A1 (en) 2014-12-03 2016-06-09 Steadymed Ltd Preservative-free treprostinil formulations and methods and devices for use with same
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US20190321290A1 (en) * 2016-01-29 2019-10-24 Mannkind Corporation Composition and method for inhalation
IL260823B2 (en) * 2016-01-29 2024-08-01 Mannkind Corp Dry powder inhaler
IL310250B2 (en) 2016-05-05 2025-09-01 Liquidia Tech Inc Terpostinil in dry powder form for the treatment of pulmonary hypertension
EP3515430A1 (en) 2016-09-26 2019-07-31 United Therapeutics Corporation Treprostinil prodrugs
CN110381951A (zh) * 2016-12-14 2019-10-25 瑞必治公司 用于治疗肺性高血压和其他肺病症的方法及组合物
US10799653B2 (en) 2017-01-09 2020-10-13 United Therapeutics Corporation Aerosol delivery device and method for manufacturing and operating the same
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
BR112020020127A2 (pt) * 2018-05-07 2021-01-05 Pharmosa Biopharm Inc. Composição farmacêutica, método de tratamento de uma doença respiratória e método para reduzir o efeito colateral de um treprostinil inalado na via respiratória superior
KR102259824B1 (ko) * 2018-07-24 2021-06-02 주식회사 마더스제약 보센탄을 함유한 약학 제제
EA202190552A1 (ru) 2018-09-18 2021-06-18 Эли Лилли Энд Компани Эрбуминовая соль трепростинила
JP7455144B2 (ja) 2019-04-29 2024-03-25 インスメッド インコーポレイテッド トレプロスチニルプロドラッグの乾燥粉末組成物およびその使用方法
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
WO2021013861A1 (en) 2019-07-22 2021-01-28 Nanomi, B.V. Sustained release trepostinil-compound microparticle compositions
EP4017588A1 (en) 2019-08-23 2022-06-29 United Therapeutics Corporation Treprostinil prodrugs
CN112569210B (zh) * 2019-09-27 2023-09-15 盈科瑞（天津）创新医药研究有限公司 一种吸入用马昔腾坦溶液及其制备方法
US12478748B2 (en) 2020-03-31 2025-11-25 Invox Belgium Nv Aerosol delivery of at least two liquid compositions
CN115916212A (zh) 2020-04-17 2023-04-04 联合治疗公司 曲前列尼尔用于治疗间质性肺病
US11013688B1 (en) * 2020-05-28 2021-05-25 Softhale Nv Methods of treatment of viral diseases
AU2021289336B2 (en) 2020-06-09 2025-08-28 Mannkind Corporation Fumaryl diketopiperidine prodrugs of treprostinil
JP2023550407A (ja) 2020-11-17 2023-12-01 ユナイテッド セラピューティクス コーポレイション 肺高血圧向けの吸入式イマチニブ
CN117062605A (zh) 2020-12-14 2023-11-14 联合治疗公司 使用曲前列环素前药治疗疾病的方法
CN117479946A (zh) 2021-03-03 2024-01-30 联合治疗公司 含曲前列环素及其前药并还包含(e)-3,6-双[4-(n-羰基-2-丙烯基)酰胺丁基]-2,5-二酮哌嗪(fdkp)的干粉组合物
CN113876748A (zh) * 2021-11-22 2022-01-04 兆科药业（广州）有限公司 一种用于治疗肺动脉高压的曲前列尼尔气溶胶吸入剂的雾化方法
CN118574627A (zh) 2022-01-21 2024-08-30 英沃克斯比利时公司 用于肺高压的治疗的曲前列环素
WO2023154705A1 (en) 2022-02-08 2023-08-17 United Therapeutics Corporation Treprostinil iloprost combination therapy
JP2025515512A (ja) * 2022-04-29 2025-05-15 兆科薬業（広州）有限公司 トレプロスチニルソフトミスト吸入剤
EP4652151A1 (en) 2023-01-19 2025-11-26 United Therapeutics Corporation Treprostinil analogs
WO2025101824A1 (en) 2023-11-09 2025-05-15 United Therapeutics Corporation Syntheses of compounds useful for producing treprostinil

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521212B1 (en) * 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3664337A (en) 1970-04-15 1972-05-23 Bio Logics Inc Respiration assembly and methods
US4001650A (en) 1975-09-02 1977-01-04 Puritan-Bennett Corporation Method and apparatus for ultrasonic transducer protection
US4007238A (en) 1976-02-25 1977-02-08 Glenn Joseph G Nebulizer for use with IPPB equipment
US4473296A (en) 1978-05-03 1984-09-25 Ppm, Inc. System and method and apparatus for a continuous aerosol monitor (CAM) using electro-optical weighing for general aerosols
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
US4281113A (en) * 1979-07-31 1981-07-28 The Upjohn Company 2,5-Inter-o-phenylene-3,4-dinor-6,9α-epoxy-6.beta.-5-iodo-PGF1 compounds
US4306075A (en) * 1980-03-28 1981-12-15 The Upjohn Company Composition and process
US4306076A (en) * 1980-04-23 1981-12-15 The Upjohn Company Inter-phenylene CBA compounds
DE3048906A1 (de) * 1980-12-19 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4349689A (en) * 1980-12-22 1982-09-14 The Upjohn Company Methano carbacyclin analogs
US4486598A (en) * 1982-02-22 1984-12-04 The Upjohn Company Carbacyclin analogs
US4495944A (en) 1983-02-07 1985-01-29 Trutek Research, Inc. Inhalation therapy apparatus
US4683330A (en) * 1984-03-08 1987-07-28 The Upjohn Company Interphenylene carbacyclin derivatives
US4668814A (en) * 1984-03-08 1987-05-26 The Upjohn Company Interphenylene carbacyclin derivatives
US4635647A (en) 1984-09-07 1987-01-13 Choksi Pradip V Incentive spirometer employing bellows air flow sensor
NZ209900A (en) 1984-10-16 1989-08-29 Univ Auckland Automatic inhaler
US4976259A (en) 1986-12-22 1990-12-11 Mountain Medical Equipment, Inc. Ultrasonic nebulizer
US5322057A (en) 1987-07-08 1994-06-21 Vortran Medical Technology, Inc. Intermittent signal actuated nebulizer synchronized to operate in the exhalation phase, and its method of use
US5080093A (en) 1987-07-08 1992-01-14 Vortran Medical Technology, Inc. Intermittant signal actuated nebulizer
FI82808C (fi) 1987-12-31 1991-04-25 Etelae Haemeen Keuhkovammayhdi Ultraljudfinfoerdelningsanordning.
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
US4984158A (en) 1988-10-14 1991-01-08 Hillsman Dean Metered dose inhaler biofeedback training and evaluation system
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
KR100246082B1 (ko) 1991-07-02 2000-04-01 인헤일, 인코오포레이티드 에어로졸화된약제를전달하는방법및장치
GB2265845B (en) 1991-11-12 1996-05-01 Medix Ltd A nebuliser and nebuliser control system
US5363842A (en) 1991-12-20 1994-11-15 Circadian, Inc. Intelligent inhaler providing feedback to both patient and medical professional
FR2694215B1 (fr) 1992-07-30 1994-10-21 Dp Medical Appareil pour générer un brouillard à partir d'un liquide, notamment un médicament.
WO1994008727A1 (en) 1992-10-16 1994-04-28 Sheiman Ultrasonic Research Foundation Pty Ltd Ultrasonic nebulising device
US5497763A (en) 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US5752502A (en) 1993-12-16 1998-05-19 King; Russell Wayne General purpose aerosol inhalation apparatus
AU735975B2 (en) 1995-02-27 2001-07-19 Toray Industries, Inc. Remedy for pulmonary heart
WO1997002857A1 (en) 1995-07-10 1997-01-30 A & D Company, Limited Atomizer
FR2746656B1 (fr) 1996-03-26 1999-05-28 System Assistance Medical Nebuliseur a capteur de pression
US6441245B1 (en) 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US6054486A (en) 1997-11-14 2000-04-25 United Technology Corporation Use of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease
DE19838711C1 (de) 1998-08-26 2000-06-21 Otto Schill Gmbh & Co Kg Inhalator zum Vernebeln von Flüssigkeiten
FR2783431B1 (fr) 1998-09-23 2001-02-02 System Assistance Medical Nebuliseur permettant de delivrer un brouillard a un patient et procede de fonctionnement d'un tel nebuliseur
SE9900369D0 (sv) * 1999-02-04 1999-02-04 Siemens Elema Ab Ultrasonic nebuliser
DE19934582C2 (de) 1999-07-23 2003-09-18 Otto Schill Gmbh & Co Kg Aerosolerzeuger
JP4777574B2 (ja) 2000-02-11 2011-09-21 レスピロニクス・レスピラトリー・ドラッグ・デリバリー・（ユーケー）・リミテッド 薬剤投与装置
DE10022795B4 (de) 2000-05-10 2005-04-14 Pari GmbH Spezialisten für effektive Inhalation Atemgesteuertes Inhalationstherapiegerät
US6242482B1 (en) 2000-06-05 2001-06-05 United Therapeutics Corporation Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
JP2004512101A (ja) * 2000-10-20 2004-04-22 グラクソ　グループ　リミテッド 吸入器
US6700025B2 (en) 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
EP1436028A4 (en) 2001-09-12 2007-04-04 Ivax U K Ltd ULTRASONIC NEBULIZER FACILITATING BREATHING AND ASSOCIATED DOSE BULB
US6626843B2 (en) 2001-09-28 2003-09-30 Deane Hillsman Respiratory timing and lung deflation method and device
US6803386B2 (en) 2002-01-16 2004-10-12 United Therapeutics Corporation Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
US20040063912A1 (en) 2002-03-15 2004-04-01 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
US20030192532A1 (en) 2002-04-12 2003-10-16 Hopkins Andrew David Nebulizer
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
JP2006507905A (ja) 2002-12-02 2006-03-09 スコット・ラボラトリーズ・インコーポレイテッド 呼吸監視システムおよび方法
US7726303B2 (en) 2003-02-25 2010-06-01 Hewlett-Packard Development Company, L.P. Controlled medicament ejection
CA2959852A1 (en) * 2003-05-22 2005-01-27 United Therapeutics Corporation Compounds and methods for delivery of prostacyclin analogs
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
JP4357230B2 (ja) * 2003-07-14 2009-11-04 帝人株式会社 酸素濃縮装置、在宅酸素療法システム
US7172557B1 (en) 2003-08-29 2007-02-06 Caldyne, Inc. Spirometer, display and method
JP4906514B2 (ja) 2003-12-16 2012-03-28 ユナイテッド セラピューティクス コーポレイション 腎臓機能改善のためのトレプロスチニルの用途
ATE473736T1 (de) 2003-12-16 2010-07-15 United Therapeutics Corp Verwendung von treprostinil zur behandlung von ischämischen läsionen
US7380550B2 (en) 2004-01-30 2008-06-03 Hewlett-Packard Development Company, L.P. Systems and methods for particle detection
DE102004009436A1 (de) 2004-02-24 2005-10-13 Boehringer Ingelheim International Gmbh Zerstäuber
BRPI0513866A (pt) 2004-07-26 2008-05-20 Cotherix Inc composição, micropartìculas, método para o tratamento da hipertensão pulmonar, e dispositivo de inalação
US7721729B2 (en) 2005-03-09 2010-05-25 Ric Investments, Llc Nebulizing drug delivery device for ventilator
US20080200449A1 (en) * 2006-05-15 2008-08-21 United Therapeutics Corporation Treprostinil administration using a metered dose inhaler
DE102006026786A1 (de) 2006-06-07 2007-12-13 Joachim Kern Dosierinhalator
US20090036465A1 (en) 2006-10-18 2009-02-05 United Therapeutics Corporation Combination therapy for pulmonary arterial hypertension
CA2678258A1 (en) 2007-02-09 2008-08-14 United Therapeutics Corporation Treprostinil treatment for interstitial lung disease and asthma
WO2010036798A1 (en) 2008-09-25 2010-04-01 Aradigm Corporation Deep lung pulmonary delivery of treprostinil
JP5649645B2 (ja) 2009-05-07 2015-01-07 ユナイテッド セラピューティクス コーポレイション プロスタサイクリンアナログの固形製剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521212B1 (en) * 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Peter R. Byron.Drug delivery devices：Issues in drug development.《Proceedings of the American Thoracic Society》.2004,第1卷(第4期),321-328. *

Also Published As

Publication number Publication date
US20220323459A1 (en) 2022-10-13
US9358240B2 (en) 2016-06-07
KR20090007797A (ko) 2009-01-20
US20080200449A1 (en) 2008-08-21
CA2654492A1 (en) 2007-11-22
EP2026816A2 (en) 2009-02-25
US10716793B2 (en) 2020-07-21
EP2026816B1 (en) 2018-10-24
US20160143868A1 (en) 2016-05-26
US20230062605A1 (en) 2023-03-02
US20120216801A1 (en) 2012-08-30
US10376525B2 (en) 2019-08-13
KR101390579B1 (ko) 2014-05-19
WO2007134292A3 (en) 2008-01-10
JP2016006066A (ja) 2016-01-14
CA2654492C (en) 2017-06-27
JP2019112434A (ja) 2019-07-11
US20200171044A1 (en) 2020-06-04
US20190365778A1 (en) 2019-12-05
ES2707548T3 (es) 2019-04-04
US9339507B2 (en) 2016-05-17
JP2014114269A (ja) 2014-06-26
US20100076083A1 (en) 2010-03-25
US11357782B2 (en) 2022-06-14
JP5797376B2 (ja) 2015-10-21
US20220008436A1 (en) 2022-01-13
JP2009537246A (ja) 2009-10-29
US20220218720A1 (en) 2022-07-14
WO2007134292A2 (en) 2007-11-22
CN101495122A (zh) 2009-07-29

Similar Documents

Publication Publication Date Title
CN101495122B (zh) 使用定量吸入器给予曲前列尼
US10940110B2 (en) Method and system for the treatment of chronic COPD with nebulized anticholinergic administrations
RU2605849C2 (ru) Введение илопроста в виде аэрозольных болюсов
WO2009134524A2 (en) Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
US20250049742A1 (en) Treatment for interstitial lung disease
KR20190030805A (ko) 폐고혈압 예방 또는 치료용 흡입제, 및 이의 투여방법
HK1190627B (en) Administration of iloprost as aerosol bolus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant